Etoricoxib operates as a highly selective COX-2 inhibitor for joint pain. Inflammation and pain signaling are suppressed by targeting specific enzymatic pathways that produce prostaglandins, specifically managing symptoms of chronic arthritis or injury.
Etoricoxib belongs to the class of drugs known as selective COX-2 inhibitors. By targeting a specific enzyme involved in inflammation, it helps reduce pain and swelling while sparing the stomach-protective COX-1 pathway. This active compound is the key ingredient in several branded and generic products marketed in Singapore.
The molecule is taken orally in tablet form and is absorbed quickly into the bloodstream. Its pharmacological profile makes it a common choice for short-term relief of musculoskeletal discomfort and other inflammatory conditions.
In Singapore, Etoricoxib appears in both single-strength tablets and fixed-dose combinations that pair it with other analgesics. Brands may use the name Etoricoxib directly, while generics label the product simply as the active substance. Tablet strengths typically range from 60 mg to 90 mg, offering flexibility for different treatment plans.
Patients obtain these medicines through hospitals, clinics, or licensed pharmacies, where the packaging clearly identifies Etoricoxib as the active component.
Etoricoxib is employed to address several common sources of pain:
The drug’s targeted action makes it useful for adults who need inflammation control without the heightened risk of gastrointestinal irritation seen with non-selective NSAIDs.
Etoricoxib selectively blocks the cyclo-oxygenase-2 enzyme, which plays a central role in producing prostaglandins that trigger inflammation, pain, and fever. By limiting this enzyme’s activity, the medication lowers the amount of inflammatory mediators in the affected area. This results in a noticeable reduction in swelling and discomfort while preserving the protective functions of COX-1 in the stomach lining.
Etoricoxib tablets should be stored at room temperature, away from moisture and direct sunlight. The typical treatment course ranges from a few days for acute gout to several weeks for chronic arthritis, depending on the condition and physician guidance. Formulation strength and dosing schedule can vary between different Etoricoxib medications; therefore, always review the label that accompanies the specific product you receive.
For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of Etoricoxib as an active substance and does not constitute medical advice. Individual Etoricoxib medications may differ in formulation, strength, and labeled directions. The information herein is offered without liability for clinical application. Patients should read the labeling of their specific product and seek guidance from a healthcare professional for personalized recommendations.
